These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36452073)

  • 21. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.
    Arcidiacono P; Webb CM; Brooke MA; Zhou H; Delaney PJ; Ng KE; Blaydon DC; Tinker A; Kelsell DP; Chikh A
    Nat Commun; 2018 Mar; 9(1):1021. PubMed ID: 29523849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iRhom2 inhibits bile duct obstruction-induced liver fibrosis.
    Sundaram B; Behnke K; Belancic A; Al-Salihi MA; Thabet Y; Polz R; Pellegrino R; Zhuang Y; Shinde PV; Xu HC; Vasilevska J; Longerich T; Herebian D; Mayatepek E; Bock HH; May P; Kordes C; Aghaeepour N; Mak TW; Keitel V; Häussinger D; Scheller J; Pandyra AA; Lang KS; Lang PA
    Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
    Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
    Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression.
    Wang L; Liu XX; Yang YM; Wang Y; Song YY; Gao S; Li LY; Zhang ZS
    Cancer Cell Int; 2021 Nov; 21(1):590. PubMed ID: 34736454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin.
    Ge CX; Xu MX; Qin YT; Gu TT; Lou DS; Li Q; Hu LF; Wang BC; Tan J
    Free Radic Biol Med; 2019 Sep; 141():67-83. PubMed ID: 31153974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
    Zhang EY; Cristofanilli M; Robertson F; Reuben JM; Mu Z; Beavis RC; Im H; Snyder M; Hofree M; Ideker T; Omenn GS; Fanayan S; Jeong SK; Paik YK; Zhang AF; Wu SL; Hancock WS
    J Proteome Res; 2013 Jun; 12(6):2805-17. PubMed ID: 23647160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation.
    Skurski J; Penniman CM; Geesala R; Dixit G; Pulipati P; Bhardwaj G; Meyerholz DK; Issuree PD; O'Neill BT; Maretzky T
    Metabolism; 2020 May; 106():154194. PubMed ID: 32135161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iRhom2 loss alleviates renal injury in long-term PM2.5-exposed mice by suppression of inflammation and oxidative stress.
    Chenxu G; Minxuan X; Yuting Q; Tingting G; Jinxiao L; Mingxing W; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Jun T
    Redox Biol; 2018 Oct; 19():147-157. PubMed ID: 30165303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological mutations reveal the key role of the cytosolic iRhom2 N-terminus for phosphorylation-independent 14-3-3 interaction and ADAM17 binding, stability, and activity.
    Bläsius K; Ludwig L; Knapp S; Flaßhove C; Sonnabend F; Keller D; Tacken N; Gao X; Kahveci-Türköz S; Grannemann C; Babendreyer A; Adrain C; Huth S; Baron JM; Ludwig A; Düsterhöft S
    Cell Mol Life Sci; 2024 Feb; 81(1):102. PubMed ID: 38409522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel functions of inactive rhomboid proteins in immunity and disease.
    Geesala R; Issuree PD; Maretzky T
    J Leukoc Biol; 2019 Oct; 106(4):823-835. PubMed ID: 31369701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. iRhoms; Its Functions and Essential Roles.
    Lee MY; Nam KH; Choi KC
    Biomol Ther (Seoul); 2016 Mar; 24(2):109-14. PubMed ID: 26869525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.
    Moerkens M; Zhang Y; Wester L; van de Water B; Meerman JH
    BMC Cancer; 2014 Apr; 14():283. PubMed ID: 24758408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.
    Jin W; Chen BB; Li JY; Zhu H; Huang M; Gu SM; Wang QQ; Chen JY; Yu S; Wu J; Shao ZM
    Mol Cell Biol; 2012 Jan; 32(1):50-63. PubMed ID: 22025675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms.
    Rahimi M; George J; Tang C
    Int J Cancer; 2010 Apr; 126(8):1850-1860. PubMed ID: 19830694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response.
    Lu XL; Zhao CH; Zhang H; Yao XL
    Biomed Pharmacother; 2017 Feb; 86():645-653. PubMed ID: 28033581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
    Zhang X; Gao D; Fang K; Guo Z; Li L
    Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding.
    Maretzky T; McIlwain DR; Issuree PD; Li X; Malapeira J; Amin S; Lang PA; Mak TW; Blobel CP
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11433-8. PubMed ID: 23801765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.